A PHASE I, OPEN-LABEL, PARALLEL-GROUP, MULTIPLE-DOSE STUDY TO DETERMINE THE PHARMACOKINETICS OF FAVIPIRAVIR IN ADULT SUBJECTS WITH HEPATIC IMPAIRMENT AND IN HEALTHY ADULT SUBJECTS
Sponsoring Agencies:
FUJIFILM PHARMACEUTICALS USA, FUJIFILM PHARMACEUTICALS USA
